AAAAAA

   
Results: 1-10 |
Results: 10
Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice
Authors: Semple, JI Newton, JL Westley, BR May, FEB
Citation: Ji. Semple et al., Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice, GUT, 48(5), 2001, pp. 648-655
The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1
Authors: Williams, MA Westley, BR May, FEB Feeney, J
Citation: Ma. Williams et al., The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1, FEBS LETTER, 493(2-3), 2001, pp. 70-74
High expression of the trefoil protein TFF1 in interval breast cancers
Authors: Crosier, M Scott, D Wilson, RG Griffiths, CDM May, FEB Westley, BR
Citation: M. Crosier et al., High expression of the trefoil protein TFF1 in interval breast cancers, AM J PATH, 159(1), 2001, pp. 215-221
Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line
Authors: Molloy, CA May, FEB Westley, BR
Citation: Ca. Molloy et al., Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line, J BIOL CHEM, 275(17), 2000, pp. 12565-12571
The human two domain trefoil protein, TFF2, is glycosylated in vivo in thestomach
Authors: May, FEB Semple, JI Newton, JL Westley, BR
Citation: Feb. May et al., The human two domain trefoil protein, TFF2, is glycosylated in vivo in thestomach, GUT, 46(4), 2000, pp. 454-459
The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach
Authors: Newton, JL Allen, A Westley, BR May, FEB
Citation: Jl. Newton et al., The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach, GUT, 46(3), 2000, pp. 312-320
Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers
Authors: Crosier, M Scott, D Wilson, RG Griffiths, CDM May, FEB Westley, BR
Citation: M. Crosier et al., Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers, CLIN CANC R, 5(10), 1999, pp. 2682-2688
Selective promoter usage of the human estrogen receptor-alpha gene and itsregulation by estrogen
Authors: Donaghue, C Westley, BR May, FEB
Citation: C. Donaghue et al., Selective promoter usage of the human estrogen receptor-alpha gene and itsregulation by estrogen, MOL ENDOCR, 13(11), 1999, pp. 1934-1950
The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS
Authors: Calnan, DP Westley, BR May, FEB Floyd, DN Marchbank, T Playford, RJ
Citation: Dp. Calnan et al., The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS, J PATHOLOGY, 188(3), 1999, pp. 312-317
Prognostic value of cathepsin D in breast cancer
Authors: Westley, BR May, FEB
Citation: Br. Westley et Feb. May, Prognostic value of cathepsin D in breast cancer, BR J CANC, 79(2), 1999, pp. 189-190
Risultati: 1-10 |